Author:
Régnier Antonia,Trüeb Ralph M.
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31:205–12. https://doi.org/10.1111/jdv.13854 (Cited in: PMID: 27573025).
2. Ortonne J, Chimenti S, Luger T, Puig L, Reid F, Trüeb RM. Scalp psoriasis: European consensus on grading and treatment algorithm. J Eur Acad Dermatol Venereol. 2009;23:1435–44. https://doi.org/10.1111/j.1468-3083.2009.03372.x (Cited in: PMID: 19614856).
3. Schlager JG, Rosumeck S, Werner RN, Jacobs A, Schmitt J, Schlager C, Nast A. Topical treatments for scalp psoriasis. Cochrane Database Syst Rev. 2016;2:009687. https://doi.org/10.1002/14651858.CD009687.pub2 (Cited in: PMID: 26915340).
4. Lebwohl M, Tyring S, Bukhalo M, Alonso-Llamazares J, Olesen M, Lowson D, Yamauchi P. Fixed combination aerosol foam calcipotriene 0.005% (Cal) plus betamethasone dipropionate 0.064% (BD) is more efficacious than Cal or BD aerosol foam alone for psoriasis vulgaris: a randomized, double-blind, multicenter, three-arm, phase 2 study. J Clin Aesthet Dermatol. 2016;9:34–41 (Cited in: PMID: 27313822).
5. Maul J-T, Anzengruber F, Conrad C, Cozzio A, Häusermann P, Jalili A, Kolios AGA, Laffitte E, Lapointe A-K, Mainetti C, et al. Topical treatment of psoriasis vulgaris: the Swiss treatment pathway. Dermatology (Basel, Switzerland). 2021;237:166–78. https://doi.org/10.1159/000512930 (Cited in: PMID: 33406520).